IBM Support

Security Bulletin: IBM Aspera Shares 1.9.14 Patch Level 1 and earlier are vulnerable to DOM XSS

Security Bulletin


Summary

DOM XSS on IBM Aspera Shares 1.9.14 Patch Level 1 and earlier could lead to HTML/JS injection and Account takeover.

Vulnerability Details

CVEID:   CVE-2020-4731
DESCRIPTION:  IBM Aspera Web Application is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
CVSS Base Score: 6.1
CVSS Temporal Score: https://exchange.xforce.ibmcloud.com/vulnerabilities/188055 for more information
CVSS Vector: (CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N)

Affected Products and Versions

Affected Product(s)Version(s)
IBM Aspera Shares1.9.14 Patch Level 1 and earlier

Remediation/Fixes

 

Products

VRMF

APAR

Remediation/First Fix

IBM Aspera Shares1.9.14 Patch Level 2

AS-420

Download Link

 

Workarounds and Mitigations

None

Get Notified about Future Security Bulletins

References

Off

Acknowledgement

The vulnerability was reported to IBM by Michele Romano and Simone Bovi.

Change History

03 Sep 2020: Initial Publication

*The CVSS Environment Score is customer environment specific and will ultimately impact the Overall CVSS Score. Customers can evaluate the impact of this vulnerability in their environments by accessing the links in the Reference section of this Security Bulletin.

Disclaimer

Review the IBM security bulletin disclaimer and definitions regarding your responsibilities for assessing potential impact of security vulnerabilities to your environment.

Document Location

Worldwide

[{"Business Unit":{"code":"BU059","label":"IBM Software w\/o TPS"},"Product":{"code":"SSRFYR","label":"IBM Aspera on Demand"},"Component":"","Platform":[{"code":"PF016","label":"Linux"},{"code":"PF033","label":"Windows"}],"Version":"1.9.14 PL2","Edition":"","Line of Business":{"code":"LOB45","label":"Automation"}}]

Document Information

Modified date:
20 February 2022

UID

ibm16326929